Journal
Advances in radiation oncology
Publication Date
2017
Volume
2
Issue
4
Inclusive Pages
572-580
Document Type
Open Access Publication
DOI
10.1016/j.adro.2017.07.003
Rights and Permissions
Acharya S, Mahmood M, Mullen D, Yang D, Tsien CI, Huang J, Perkins SM, Rich K, Chicoine M, Leuthardt E, Dowling J, Dunn G, Keller J, Robinson CG, Abraham C (2017) Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents. Advances in Radiation Oncology, 2(4): 572-580. https://doi.org/10.1016/j.adro.2017.07.003 © 2017 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Acharya, Sahaja; Mahmood, Mustafaa; Mullen, Daniel; Yang, Deshan; Tsien, Christina I.; Huang, Jiayi; Perkins, Stephanie M.; Rich, Keith; Chicoine, Michael; Leuthardt, Eric; Dowling, Joshua; Dunn, Gavin; Keller, Jesse; Robinson, Clifford G.; and Abraham, Christopher, "Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents." Advances in radiation oncology. 2, 4. 572-580. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6412
Figure S1. Distant intracranial control of MBMs without prior whole brain radiation stratified by receipt of immunotherapy (anti-CTLA-4/anti-PD-1) or targeted therapy (BRAF/MEK inhibitors).
1-s2.0-S2452109417301082-mmc2.docx (12 kB)
Table S1. Univariate and Multivariate Analysis for overall survival.